Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
AVMA News
MAY 22, 2023
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, will soon hit the market.
368 
Let's personalize your content